NYSE - Delayed Quote USD

Hims & Hers Health, Inc. (HIMS)

14.57 +0.53 (+3.77%)
At close: May 17 at 4:00 PM EDT
14.58 +0.01 (+0.07%)
After hours: May 17 at 7:59 PM EDT
Loading Chart for HIMS
DELL
  • Previous Close 14.04
  • Open 14.12
  • Bid --
  • Ask --
  • Day's Range 14.00 - 14.67
  • 52 Week Range 5.65 - 17.16
  • Volume 5,436,821
  • Avg. Volume 6,703,308
  • Market Cap (intraday) 3.129B
  • Beta (5Y Monthly) 0.96
  • PE Ratio (TTM) --
  • EPS (TTM) -0.01
  • Earnings Date Aug 5, 2024 - Aug 9, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 16.33

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

www.forhims.com

1,046

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HIMS

Performance Overview: HIMS

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HIMS
63.71%
S&P 500
11.18%

1-Year Return

HIMS
39.03%
S&P 500
29.04%

3-Year Return

HIMS
64.82%
S&P 500
27.06%

5-Year Return

HIMS
48.98%
S&P 500
76.34%

Compare To: HIMS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HIMS

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    3.13B

  • Enterprise Value

    2.94B

  • Trailing P/E

    --

  • Forward P/E

    97.09

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.26

  • Price/Book (mrq)

    9.08

  • Enterprise Value/Revenue

    3.06

  • Enterprise Value/EBITDA

    1.39k

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.25%

  • Return on Assets (ttm)

    -0.79%

  • Return on Equity (ttm)

    -0.71%

  • Revenue (ttm)

    959.4M

  • Net Income Avi to Common (ttm)

    -2.35M

  • Diluted EPS (ttm)

    -0.01

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    203.59M

  • Total Debt/Equity (mrq)

    3.43%

  • Levered Free Cash Flow (ttm)

    60.33M

Research Analysis: HIMS

Company Insights: HIMS

Research Reports: HIMS

People Also Watch